Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Candida albicans | 25 | 2021 | 176 | 4.580 |
Why?
|
| Fungal Proteins | 12 | 2021 | 142 | 2.180 |
Why?
|
| Candidiasis | 15 | 2018 | 89 | 2.160 |
Why?
|
| Hyphae | 15 | 2021 | 36 | 2.030 |
Why?
|
| Gene Expression Regulation, Fungal | 9 | 2021 | 69 | 1.180 |
Why?
|
| Repressor Proteins | 6 | 2016 | 273 | 0.900 |
Why?
|
| Antifungal Agents | 8 | 2019 | 169 | 0.900 |
Why?
|
| Biofilms | 9 | 2019 | 184 | 0.730 |
Why?
|
| Neuregulin-1 | 3 | 2016 | 26 | 0.720 |
Why?
|
| Virulence | 12 | 2019 | 246 | 0.600 |
Why?
|
| Mice, Inbred BALB C | 8 | 2017 | 694 | 0.430 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 1596 | 0.380 |
Why?
|
| Genetic Engineering | 3 | 2007 | 37 | 0.380 |
Why?
|
| GATA Transcription Factors | 1 | 2012 | 3 | 0.380 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 131 | 0.370 |
Why?
|
| Fungal Vaccines | 2 | 2009 | 45 | 0.350 |
Why?
|
| Mice | 14 | 2017 | 6644 | 0.340 |
Why?
|
| Doxycycline | 3 | 2011 | 32 | 0.320 |
Why?
|
| DNA-Binding Proteins | 4 | 2010 | 561 | 0.310 |
Why?
|
| Stress, Physiological | 2 | 2012 | 172 | 0.310 |
Why?
|
| Genome, Fungal | 2 | 2019 | 28 | 0.280 |
Why?
|
| Mycoses | 1 | 2005 | 31 | 0.230 |
Why?
|
| Animals | 17 | 2017 | 16992 | 0.230 |
Why?
|
| Yeasts | 1 | 2003 | 19 | 0.210 |
Why?
|
| Kidney | 5 | 2011 | 372 | 0.200 |
Why?
|
| Endothelial Cells | 3 | 2011 | 329 | 0.180 |
Why?
|
| Membrane Proteins | 1 | 2006 | 561 | 0.180 |
Why?
|
| Transcription Factors | 2 | 2006 | 735 | 0.180 |
Why?
|
| Lactams, Macrocyclic | 1 | 2021 | 8 | 0.170 |
Why?
|
| Benzoquinones | 1 | 2021 | 47 | 0.170 |
Why?
|
| Small Molecule Libraries | 2 | 2017 | 62 | 0.150 |
Why?
|
| Streptococcus gordonii | 1 | 2019 | 2 | 0.150 |
Why?
|
| Microbial Interactions | 1 | 2019 | 11 | 0.150 |
Why?
|
| Proteomics | 3 | 2006 | 378 | 0.150 |
Why?
|
| Gene Expression | 2 | 2012 | 701 | 0.140 |
Why?
|
| Amides | 1 | 2018 | 71 | 0.140 |
Why?
|
| Benzamides | 1 | 2017 | 81 | 0.130 |
Why?
|
| Female | 11 | 2017 | 24698 | 0.130 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 704 | 0.120 |
Why?
|
| Candida | 2 | 2006 | 42 | 0.110 |
Why?
|
| Cell Adhesion | 2 | 2019 | 238 | 0.110 |
Why?
|
| Drug Discovery | 1 | 2016 | 108 | 0.110 |
Why?
|
| Virulence Factors | 4 | 2019 | 125 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 74 | 0.100 |
Why?
|
| Culture Media | 2 | 2010 | 96 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2014 | 245 | 0.100 |
Why?
|
| RNA Stability | 1 | 2012 | 28 | 0.090 |
Why?
|
| Open Reading Frames | 1 | 2012 | 79 | 0.090 |
Why?
|
| Tetracycline | 1 | 2011 | 17 | 0.090 |
Why?
|
| Actins | 2 | 2003 | 164 | 0.090 |
Why?
|
| Candidiasis, Oral | 1 | 2011 | 24 | 0.090 |
Why?
|
| Humans | 14 | 2019 | 43102 | 0.090 |
Why?
|
| Mouth Mucosa | 1 | 2011 | 30 | 0.080 |
Why?
|
| Mutation | 5 | 2011 | 1177 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2011 | 168 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 2 | 2011 | 209 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2011 | 75 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2003 | 321 | 0.080 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 78 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 592 | 0.080 |
Why?
|
| Nitrogen | 1 | 2010 | 84 | 0.070 |
Why?
|
| Vaccines, Attenuated | 1 | 2009 | 75 | 0.070 |
Why?
|
| Oxygen | 1 | 2010 | 218 | 0.070 |
Why?
|
| Vaccines, Synthetic | 1 | 2009 | 80 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 300 | 0.070 |
Why?
|
| Spleen | 2 | 2011 | 204 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2009 | 368 | 0.070 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 73 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2007 | 158 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2007 | 97 | 0.060 |
Why?
|
| Fluconazole | 2 | 2006 | 41 | 0.060 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2006 | 1 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1124 | 0.060 |
Why?
|
| Antigens, Fungal | 1 | 2006 | 34 | 0.060 |
Why?
|
| Mice, Nude | 1 | 2007 | 408 | 0.060 |
Why?
|
| Family Health | 1 | 2006 | 55 | 0.060 |
Why?
|
| Tenascin | 1 | 2006 | 5 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2006 | 24 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 386 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 526 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 110 | 0.060 |
Why?
|
| Laminin | 1 | 2006 | 58 | 0.060 |
Why?
|
| DNA, Fungal | 1 | 2005 | 49 | 0.060 |
Why?
|
| Fibronectins | 1 | 2006 | 69 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2005 | 91 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2017 | 127 | 0.060 |
Why?
|
| Time Factors | 2 | 2007 | 1857 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 310 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 193 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 2 | 2003 | 116 | 0.050 |
Why?
|
| Cell Surface Extensions | 1 | 2003 | 9 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 28 | 0.050 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 2003 | 2 | 0.050 |
Why?
|
| Pharyngitis | 1 | 2003 | 5 | 0.050 |
Why?
|
| Candida glabrata | 1 | 2003 | 5 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2019 | 536 | 0.050 |
Why?
|
| Farnesol | 1 | 2002 | 5 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 311 | 0.050 |
Why?
|
| Survival Rate | 1 | 2003 | 355 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 1869 | 0.050 |
Why?
|
| Pseudopodia | 1 | 2001 | 17 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 403 | 0.040 |
Why?
|
| Mouth | 1 | 2019 | 54 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 386 | 0.040 |
Why?
|
| Heart-Lung Machine | 1 | 1998 | 1 | 0.040 |
Why?
|
| Diuretics, Osmotic | 1 | 1998 | 4 | 0.040 |
Why?
|
| Diuresis | 1 | 1998 | 7 | 0.040 |
Why?
|
| Mannitol | 1 | 1998 | 11 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2018 | 42 | 0.040 |
Why?
|
| Saliva | 1 | 2019 | 119 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1998 | 23 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 195 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 456 | 0.030 |
Why?
|
| Cytokines | 2 | 2011 | 678 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 411 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 432 | 0.030 |
Why?
|
| Brain | 1 | 2003 | 1472 | 0.030 |
Why?
|
| Drug Resistance, Fungal | 2 | 2006 | 33 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 945 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 2012 | 68 | 0.020 |
Why?
|
| Cell Line | 2 | 2009 | 1410 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2011 | 20 | 0.020 |
Why?
|
| Triazoles | 1 | 2012 | 102 | 0.020 |
Why?
|
| beta-Defensins | 1 | 2011 | 4 | 0.020 |
Why?
|
| Response Elements | 1 | 2011 | 55 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2016 | 2157 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2011 | 67 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 96 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1991 | 124 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 278 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 224 | 0.020 |
Why?
|
| Adhesiveness | 1 | 2009 | 5 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1991 | 199 | 0.020 |
Why?
|
| Shear Strength | 1 | 2009 | 25 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 281 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 934 | 0.020 |
Why?
|
| Protein Binding | 2 | 2003 | 1082 | 0.020 |
Why?
|
| Cross Infection | 1 | 2008 | 48 | 0.020 |
Why?
|
| Mercaptoethanol | 1 | 2006 | 13 | 0.020 |
Why?
|
| Acetabulum | 1 | 2006 | 3 | 0.020 |
Why?
|
| Hip Joint | 1 | 2006 | 15 | 0.020 |
Why?
|
| Radiography | 1 | 2006 | 71 | 0.020 |
Why?
|
| Binding Sites | 2 | 2003 | 671 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 102 | 0.020 |
Why?
|
| Femur | 1 | 2006 | 47 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 67 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2006 | 51 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 2001 | 462 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2005 | 27 | 0.010 |
Why?
|
| Blotting, Western | 2 | 2001 | 883 | 0.010 |
Why?
|
| Vaccination | 1 | 2006 | 355 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2003 | 64 | 0.010 |
Why?
|
| Neck | 1 | 2003 | 20 | 0.010 |
Why?
|
| Head | 1 | 2003 | 28 | 0.010 |
Why?
|
| Plankton | 1 | 2002 | 13 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 210 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 196 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 1175 | 0.010 |
Why?
|
| Antibodies | 1 | 2003 | 144 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 196 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 150 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2002 | 159 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 1546 | 0.010 |
Why?
|
| Cell Communication | 1 | 2002 | 114 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 712 | 0.010 |
Why?
|
| Actin-Related Protein 2 | 1 | 2001 | 2 | 0.010 |
Why?
|
| Actin-Related Protein 3 | 1 | 2001 | 2 | 0.010 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2001 | 4 | 0.010 |
Why?
|
| Shigella | 1 | 2001 | 11 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2001 | 64 | 0.010 |
Why?
|
| Bradykinin | 1 | 2001 | 25 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 51 | 0.010 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2001 | 25 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2001 | 90 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 197 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 278 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 256 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 296 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 423 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 518 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 2544 | 0.010 |
Why?
|
| Male | 3 | 2006 | 23409 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 1998 | 1 | 0.010 |
Why?
|
| Cardioplegic Solutions | 1 | 1998 | 2 | 0.010 |
Why?
|
| Plasma Substitutes | 1 | 1998 | 2 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1998 | 33 | 0.010 |
Why?
|
| Body Water | 1 | 1998 | 26 | 0.010 |
Why?
|
| United States | 1 | 2008 | 5205 | 0.010 |
Why?
|
| Middle Aged | 2 | 2003 | 12222 | 0.010 |
Why?
|
| Hydroxyapatites | 1 | 1991 | 3 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1991 | 7 | 0.010 |
Why?
|
| Diglycerides | 1 | 1991 | 9 | 0.010 |
Why?
|
| Chromatography | 1 | 1991 | 17 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 43 | 0.010 |
Why?
|
| Durapatite | 1 | 1991 | 18 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1991 | 168 | 0.010 |
Why?
|
| Bis-Trimethylammonium Compounds | 1 | 1950 | 1 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 1950 | 54 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1991 | 168 | 0.010 |
Why?
|
| Mammals | 1 | 1991 | 112 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 695 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1991 | 986 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1950 | 666 | 0.000 |
Why?
|
| Hypertension | 1 | 1950 | 835 | 0.000 |
Why?
|